INSMED Inc — Director's Dealing 2023

Jan 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-01-05

Reporting Person: Wise John Drayton (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-05	Common Stock	S	1160	$19.74	Disposed	70453	Direct
2023-01-05	Common Stock	A	7598	—	Acquired	78051	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-05	Stock Option (right to buy)	$19.74	A	34860	Acquired	2033-01-05	Common Stock (34860.0)	Direct

Footnotes

F1: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F3: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

F4: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.